Jacobs Levy Equity Management, Inc Kodiak Sciences Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 420,705 shares of KOD stock, worth $3.58 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
420,705
Previous 685,198
38.6%
Holding current value
$3.58 Million
Previous $1.93 Million
18.49%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding KOD
# of Institutions
101Shares Held
41MCall Options Held
73.7KPut Options Held
0-
Baker Bros. Advisors LP New York, NY17.3MShares$147 Million0.65% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$32.8 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.06MShares$17.5 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$16.8 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.82MShares$15.5 Million0.0% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $443M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...